PLA2G7 and diabetes mellitus: In GoDARTS, the higher risk group were participants with poorly controlled diabetes and Lp-PLA2 activity in Q4, while the lower risk group were participants with well-controlled diabetes and LpPLA2 activity in Q1–Q3.